Literature DB >> 11502517

Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.

G Ramage1, K Vande Walle, B L Wickes, J L López-Ribot.   

Abstract

Candida albicans is implicated in many biomaterial-related infections. Typically, these infections are associated with biofilm formation. Cells in biofilms display phenotypic traits that are dramatically different from those of their free-floating planktonic counterparts and are notoriously resistant to antimicrobial agents. Consequently, biofilm-related infections are inherently difficult to treat and to fully eradicate with normal treatment regimens. Here, we report a rapid and highly reproducible microtiter-based colorimetric assay for the susceptibility testing of fungal biofilms, based on the measurement of metabolic activities of the sessile cells by using a formazan salt reduction assay. The assay was used for in vitro antifungal susceptibility testing of several C. albicans strains grown as biofilms against amphotericin B and fluconazole and the increased resistance of C. albicans biofilms against these antifungal agents was demonstrated. Because of its simplicity, compatibility with a widely available 96-well microplate platform, high throughput, and automation potential, we believe this assay represents a promising tool for the standardization of in vitro antifungal susceptibility testing of fungal biofilms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502517      PMCID: PMC90680          DOI: 10.1128/AAC.45.9.2475-2479.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

Review 1.  Riddle of biofilm resistance.

Authors:  K Lewis
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 2.  Candida biofilms and their susceptibility to antifungal agents.

Authors:  G S Baillie; L J Douglas
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

Review 3.  The biofilm glycocalyx as a resistance factor.

Authors:  B D Hoyle; J Jass; J W Costerton
Journal:  J Antimicrob Chemother       Date:  1990-07       Impact factor: 5.790

Review 4.  Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response.

Authors:  P Gilbert; P J Collier; M R Brown
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

5.  Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro.

Authors:  B Amorena; E Gracia; M Monzón; J Leiva; C Oteiza; M Pérez; J L Alabart; J Hernández-Yago
Journal:  J Antimicrob Chemother       Date:  1999-07       Impact factor: 5.790

6.  Susceptibility of bacterial biofilms to tobramycin: role of specific growth rate and phase in the division cycle.

Authors:  D J Evans; M R Brown; D G Allison; P Gilbert
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

7.  Expression of the multiple antibiotic resistance operon (mar) during growth of Escherichia coli as a biofilm.

Authors:  T Maira-Litrán; D G Allison; P Gilbert
Journal:  J Appl Microbiol       Date:  2000-02       Impact factor: 3.772

8.  Adhesive colonization of biomaterials and antibiotic resistance.

Authors:  A G Gristina; C D Hobgood; L X Webb; Q N Myrvik
Journal:  Biomaterials       Date:  1987-11       Impact factor: 12.479

Review 9.  Oral colonization by Candida albicans.

Authors:  R D Cannon; W L Chaffin
Journal:  Crit Rev Oral Biol Med       Date:  1999

10.  Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate.

Authors:  D J Evans; D G Allison; M R Brown; P Gilbert
Journal:  J Antimicrob Chemother       Date:  1991-02       Impact factor: 5.790

View more
  246 in total

1.  E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis.

Authors:  Nao-Aki Watanabe; Mamiko Miyazaki; Takaaki Horii; Koji Sagane; Kappei Tsukahara; Katsura Hata
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion.

Authors:  Priya Uppuluri; Anand Srinivasan; Anand Ramasubramanian; Jose L Lopez-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

Review 3.  Candida biofilms: an update.

Authors:  Gordon Ramage; Stephen P Saville; Derek P Thomas; José L López-Ribot
Journal:  Eukaryot Cell       Date:  2005-04

4.  Candida albicans Amphotericin B-Tolerant Persister Formation is Closely Related to Surface Adhesion.

Authors:  Jing Sun; Zhigang Li; Haoyue Chu; Jing Guo; Guangshui Jiang; Qingguo Qi
Journal:  Mycopathologia       Date:  2015-09-18       Impact factor: 2.574

5.  In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilms.

Authors:  Semanti Sarkar; Priya Uppuluri; Christopher G Pierce; Jose L Lopez-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

Review 6.  Candida infections of medical devices.

Authors:  Erna M Kojic; Rabih O Darouiche
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  Expression of UME6, a key regulator of Candida albicans hyphal development, enhances biofilm formation via Hgc1- and Sun41-dependent mechanisms.

Authors:  Mohua Banerjee; Priya Uppuluri; Xiang R Zhao; Patricia L Carlisle; Geethanjali Vipulanandan; Cristina C Villar; José L López-Ribot; David Kadosh
Journal:  Eukaryot Cell       Date:  2012-12-07

8.  Real-time microscopic observation of Candida biofilm development and effects due to micafungin and fluconazole.

Authors:  Yukihiro Kaneko; Susumu Miyagawa; On Takeda; Masateru Hakariya; Satoru Matsumoto; Hideaki Ohno; Yoshitsugu Miyazaki
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

9.  Development and characterization of an in vivo central venous catheter Candida albicans biofilm model.

Authors:  D Andes; J Nett; P Oschel; R Albrecht; K Marchillo; A Pitula
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

10.  Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection.

Authors:  Y Jin; H K Yip; Y H Samaranayake; J Y Yau; L P Samaranayake
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.